Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
With the growing prevalence of type 2 diabetes mellitus (T2DM) the possibility of treating it with available drugs is one of the main issues. Although glycemic control and reduction of micro- and macrovascular outcomes remain important aspects of treatment, the main limiting factors are the availabi...
Guardado en:
Autores principales: | Nina A. Petunina, Irina A. Kuzina, Ludmila V. Nedosugova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1491da5627b94711b20e2426c61162cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
por: I. V. Kononenko, et al.
Publicado: (2021) -
Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes
por: Natalia Р. Trubitsyna, et al.
Publicado: (2019) -
Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011) -
National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment
por: Gagik Radikovich Galstyan
Publicado: (2014) -
A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
por: Yury Shavkatovich Khalimov, et al.
Publicado: (2011)